AJU IB Investment Co., Ltd.

Est. AUM

$30.5M

13F long equity, this entity only

Positions

Period

Mar 2026 (Q1)

SEC EDGAR

Mar 2026 (Q1)

#	Issuer	Class	Value	Shares	% Portfolio	Discretion
1	ARCELLX INC	COMMON STOCK	$25.7M	223486	84.07%	SOLE
2	KYMERA THERAPEUTICS INC	COM	$1.6M	19648	5.36%	SOLE
3	SEER INC	COM CL A	$1.5M	816375	5.06%	SOLE
4	RALLYBIO CORP	COM	$846K	94334	2.77%	SOLE
5	SUTRO BIOPHARMA INC	COM SHS	$436K	17500	1.43%	SOLE
6	XILIO THERAPEUTICS INC	COM	$401K	47695	1.31%	SOLE

Values in USD (reported in $thousands on 13F). Source: SEC EDGAR.